Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

R Wood is funded in part by the Cost–Effectiveness of Preventing AIDS Complications initiative, funded by the NIH (NIH: 5 R01AI058736–02), the International Epidemiologic Database to Evaluate Aids with a grant from the National Institute of Allergy and Infectious Diseases (NIAID: 5U01AI069924–02); the USAID Right to Care (CA 674 A 00 08 0000 700) and the South African Centre for Epidemiological Modeling and Analysis. SD Lawn is funded by the Wellcome Trust (London, UK) with grant number 074641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.